Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2017.10.011
Abstract: Introduction Although programmed cell death 1 (PD‐1)/programmed death ligand 1 (PD‐L1) inhibitors have shown some efficacy in treating advanced NSCLC, their benefits are limited to only a subset of patients. Advanced NSCLC is generally treated… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.04.017
Abstract: OBJECTIVE To determine the efficacy of chemotherapy after failed initial treatment in patients with high risk gestational trophoblastic neoplasia (GTN). METHODS We performed a retrospective IRB-approved chart review of all patients with GTN seen at… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2016.245
Abstract: Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "RSC Advances"
DOI: 10.1039/c7ra13298k
Abstract: Acute myeloid leukemia (AML) is a group of hematological malignancies causing high mortality around the world. However, the treatment of AML is still one of the most formidable challenges. In this study, we employed a… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Mycoses"
DOI: 10.1111/myc.13384
Abstract: BACKGROUND In patients with relapsed/refractory acute myeloid leukemia (R/R AML) who received salvage chemotherapy, limited and not updated studies explored the incidence of invasive aspergillosis (IA) and the role of antifungal prophylaxis (AP). The aims… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Oncology"
DOI: 10.1159/000507219
Abstract: Objective: Nivolumab is recommended as a third-line treatment in patients with unresectable advanced or recurrent gastric cancer. Although recent studies have demonstrated the prognostic impact of salvage chemotherapy after immune checkpoint inhibitors in several malignancies,… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Acta Haematologica"
DOI: 10.1159/000511144
Abstract: Introduction: The overall outcome of patients with refractory AML (rAML) remains poor. Though allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered as the only curative therapy, it is routinely recommended only for patients after remission… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.420
Abstract: 420Background: Only scarce data exist on the management of residual masses in men who have received two lines of chemotherapy for advanced seminoma. Due to the lack of data, the role of PET scannin... read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "AntiCancer Research"
DOI: 10.21873/anticanres.14186
Abstract: Aim: The current study reports the type of salvage chemotherapy following osimertinib and its treatment efficacy in patients with non-small-cell lung carcinoma (NSCLC) who acquire resistance to osimertinib. Patients and Methods: In this retrospective cohort… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancers"
DOI: 10.3390/cancers12082299
Abstract: Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT… read more here.